ARCHIVES

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

This article is from The Cancer Letter archive.

Vol. 36 No. 44 | December 3, 2010

Download PDF Visit The Full Archive

Related Articles

NCI To Offer Planning Grants for New Centers

November 9, 1990

ET2 Meber discusses Grants Funding Issue, Says Problem Is Money

July 23, 1993

In Brief: Einhorn Named Karnofsky Lecturer; Consensus Conferences On Colon, Breast Cancer Planned

February 2, 1990

Consructio Needs Over Next Five Years Total Estimated $696 Million; NCI Share-$132 Million

January 19, 1979

Announcement, RFA On Drug Discovery Groups Coming

December 10, 1982

President, Congress Decry Practice Of “Drive-Through Mastectomies

February 21, 1997